| Long-term survival for patients with non–small-cell lung cancer with intratumoral lymphoid structures MC Dieu-Nosjean, M Antoine, C Danel, D Heudes, M Wislez, V Poulot, ... Journal of Clinical Oncology 26 (27), 4410-4417, 2008 | 1013 | 2008 |
| Lung Cancer That Harbors an HER2 Mutation: Epidemiologic Characteristics and Therapeutic Perspectives J Mazières, S Peters, B Lepage, AB Cortot, F Barlesi, M Beau-Faller, ... Journal of clinical oncology 31 (16), 1997-2003, 2013 | 742 | 2013 |
| Primary pulmonary lymphoma J Cadranel, M Wislez, M Antoine European Respiratory Journal 20 (3), 750-762, 2002 | 568 | 2002 |
| Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer JS Lim, A Ibaseta, MM Fischer, B Cancilla, G O’Young, S Cristea, VC Luca, ... Nature 545 (7654), 360-364, 2017 | 386 | 2017 |
| Nfib promotes metastasis through a widespread increase in chromatin accessibility SK Denny, D Yang, CH Chuang, JJ Brady, JS Lim, BM Grüner, SH Chiou, ... Cell 166 (2), 328-342, 2016 | 342 | 2016 |
| Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network M Beau-Faller, N Prim, AM Ruppert, I Nanni-Metéllus, R Lacave, L Lacroix, ... Annals of oncology 25 (1), 126-131, 2014 | 335 | 2014 |
| Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort J Mazières, F Barlesi, T Filleron, B Besse, I Monnet, M Beau-Faller, ... Annals of Oncology 27 (2), 281-286, 2016 | 323 | 2016 |
| Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death M Wislez, N Rabbe, J Marchal, B Milleron, B Crestani, C Mayaud, ... Cancer research 63 (6), 1405-1412, 2003 | 295 | 2003 |
| TP53, STK11, and EGFR Mutations Predict Tumor Immune Profile and the Response to Anti–PD-1 in Lung Adenocarcinoma J Biton, A Mansuet-Lupo, N Pécuchet, M Alifano, H Ouakrim, J Arrondeau, ... Clinical Cancer Research 24 (22), 5710-5723, 2018 | 290 | 2018 |
| Clinical characteristics and prognostic factors of pulmonary MALT lymphoma R Borie, M Wislez, G Thabut, M Antoine, A Rabbat, LJ Couderc, I Monnet, ... European Respiratory Journal 34 (6), 1408-1416, 2009 | 246 | 2009 |
| Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset I Tillie-Leblond, M Wislez, D Valeyre, B Crestani, A Rabbat, D Israel-Biet, ... Thorax 63 (1), 53-59, 2008 | 217 | 2008 |
| Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma T Vieira, N Girard, M Ung, I Monnet, A Cazes, P Bonnette, M Duruisseaux, ... Journal of Thoracic Oncology 8 (12), 1574-1577, 2013 | 212 | 2013 |
| Acute Respiratory Failure Following HAART Introduction in Patients Treated for Pneumocystis carinii Pneumonia M WISLEZ, E BERGOT, M ANTOINE, A PARROT, MF CARETTE, ... American journal of respiratory and critical care medicine 164 (5), 847-851, 2001 | 199 | 2001 |
| SRC-family kinases are activated in non-small cell lung cancer and promote the survival of epidermal growth factor receptor-dependent cell lines J Zhang, S Kalyankrishna, M Wislez, N Thilaganathan, B Saigal, W Wei, ... The American journal of pathology 170 (1), 366-376, 2007 | 184 | 2007 |
| High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras M Wislez, N Fujimoto, JG Izzo, AE Hanna, DD Cody, RR Langley, H Tang, ... Cancer research 66 (8), 4198-4207, 2006 | 181 | 2006 |
| Inhibition of mammalian target of rapamycin reverses alveolar epithelial neoplasia induced by oncogenic K-ras M Wislez, ML Spencer, JG Izzo, DM Juroske, K Balhara, DD Cody, ... Cancer research 65 (8), 3226-3235, 2005 | 181 | 2005 |
| Lymphoma of pulmonary mucosa-associated lymphoid tissue: CT scan findings and pathological correlations M Wislez, J Cadranel, M Antoine, B Milleron, M Bazot, C Mayaud, ... European Respiratory Journal 14 (2), 423-429, 1999 | 179 | 1999 |
| High expression of ErbB family members and their ligands in lung adenocarcinomas that are sensitive to inhibition of epidermal growth factor receptor N Fujimoto, M Wislez, J Zhang, K Iwanaga, J Dackor, AE Hanna, ... Cancer research 65 (24), 11478-11485, 2005 | 171 | 2005 |
| Role of atmospheric pollution on the natural history of idiopathic pulmonary fibrosis L Sesé, H Nunes, V Cottin, S Sanyal, M Didier, Z Carton, D Israel-Biet, ... Thorax 73 (2), 145-150, 2018 | 168 | 2018 |
| Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literature C Comarmond, B Crestani, A Tazi, B Hervier, S Adam-Marchand, ... Medicine 93 (24), 340-349, 2014 | 165 | 2014 |
